US Stock MarketDetailed Quotes

AUPH Aurinia Pharmaceuticals

Watchlist
  • 4.810
  • -0.100-2.04%
Close Apr 18 16:00 ET
  • 4.800
  • -0.010-0.21%
Post 17:27 ET
695.61MMarket Cap-8907P/E (TTM)

Aurinia Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
30.95%175.51M
58.59%45.1M
-2.27%54.52M
47.19%41.49M
59.12%34.41M
193.89%134.03M
21.50%28.44M
280.30%55.78M
325.85%28.19M
2,265.97%21.63M
Operating revenue
30.95%175.51M
58.59%45.1M
-2.27%54.52M
47.19%41.49M
59.12%34.41M
193.89%134.03M
21.50%28.44M
280.30%55.78M
325.85%28.19M
2,265.97%21.63M
Cost of revenue
149.79%14.15M
296.11%5.4M
176.62%6.77M
-2.25%1.56M
64.45%421K
419.16%5.66M
183.16%1.36M
863.39%2.45M
419.16%1.6M
433.33%256K
Gross profit
25.71%161.37M
46.64%39.7M
-10.47%47.75M
50.16%39.93M
59.05%33.99M
188.37%128.37M
18.10%27.07M
270.03%53.33M
321.29%26.59M
2,367.55%21.37M
Operating expense
5.51%253.06M
25.74%69.37M
1.87%64.01M
-10.35%56.1M
7.29%63.57M
6.48%239.84M
-0.82%55.17M
-2.99%62.83M
17.09%62.58M
15.25%59.25M
Selling and administrative expenses
-0.68%195.04M
5.47%50.07M
-8.45%47.76M
-8.64%47.08M
10.90%50.12M
13.16%196.37M
6.05%47.47M
16.85%52.17M
16.27%51.53M
13.55%45.2M
-General and administrative expense
-0.68%195.04M
5.47%50.07M
-8.45%47.76M
-8.64%47.08M
10.90%50.12M
13.16%196.37M
6.05%47.47M
16.85%52.17M
16.27%51.53M
13.55%45.2M
Research and development costs
10.34%49.64M
3.63%10.23M
23.99%13.61M
9.76%12.65M
4.26%13.16M
-12.03%44.99M
-11.47%9.87M
-45.32%10.97M
14.21%11.53M
28.34%12.62M
Other operating expenses
650.16%8.38M
518.16%9.07M
950.48%2.65M
-662.61%-3.63M
-79.78%290K
-365.33%-1.52M
-661.40%-2.17M
-665.45%-311K
50.78%-476K
-19.03%1.43M
Operating profit
17.74%-91.69M
-5.60%-29.67M
-71.21%-16.26M
55.07%-16.17M
21.90%-29.58M
38.32%-111.47M
14.08%-28.1M
81.14%-9.5M
23.65%-35.99M
25.05%-37.88M
Net non-operating interest income expense
177.88%14.22M
12.00%3.26M
112.70%3.11M
735.61%4.04M
1,355.73%3.81M
867.49%5.12M
2,568.81%2.91M
1,281.13%1.46M
240.14%483K
52.33%262K
Non-operating interest income
232.10%17M
57.03%4.57M
208.33%4.51M
749.07%4.1M
1,355.73%3.81M
867.49%5.12M
2,568.81%2.91M
1,281.13%1.46M
240.14%483K
52.33%262K
Non-operating interest expense
--2.78M
--1.31M
--1.4M
--65K
----
--0
--0
--0
--0
----
Other net income (expense)
Income before tax
27.16%-77.47M
-4.86%-26.42M
-63.65%-13.15M
65.83%-12.13M
31.50%-25.77M
40.98%-106.35M
22.72%-25.19M
84.01%-8.04M
24.44%-35.51M
25.31%-37.62M
Income tax
-69.86%551K
-46.32%459K
-68.76%298K
-7,233.33%-642K
4,260.00%436K
140.53%1.83M
17.77%855K
11,825.00%954K
-50.00%9K
25.00%10K
Net income
27.88%-78.02M
-3.18%-26.88M
-49.59%-13.45M
67.64%-11.49M
30.36%-26.21M
40.22%-108.18M
21.84%-26.05M
82.11%-8.99M
24.45%-35.52M
25.31%-37.63M
Net income continuous Operations
27.88%-78.02M
-3.18%-26.88M
-49.59%-13.45M
67.64%-11.49M
30.36%-26.21M
40.22%-108.18M
21.84%-26.05M
82.11%-8.99M
24.45%-35.52M
25.31%-37.63M
Minority interest income
Net income attributable to the parent company
27.88%-78.02M
-3.18%-26.88M
-49.59%-13.45M
67.64%-11.49M
30.36%-26.21M
40.22%-108.18M
21.84%-26.05M
82.11%-8.99M
24.45%-35.52M
25.31%-37.63M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
27.88%-78.02M
-3.18%-26.88M
-49.59%-13.45M
67.64%-11.49M
30.36%-26.21M
40.22%-108.18M
21.84%-26.05M
82.11%-8.99M
24.45%-35.52M
25.31%-37.63M
Basic earnings per share
28.95%-0.54
0.00%-0.18
-50.00%-0.09
68.00%-0.08
33.33%-0.18
45.71%-0.76
28.00%-0.18
84.62%-0.06
32.43%-0.25
32.50%-0.27
Diluted earnings per share
28.95%-0.54
0.00%-0.18
-50.00%-0.09
68.00%-0.08
33.33%-0.18
45.71%-0.76
28.00%-0.18
84.62%-0.06
32.43%-0.25
32.50%-0.27
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 30.95%175.51M58.59%45.1M-2.27%54.52M47.19%41.49M59.12%34.41M193.89%134.03M21.50%28.44M280.30%55.78M325.85%28.19M2,265.97%21.63M
Operating revenue 30.95%175.51M58.59%45.1M-2.27%54.52M47.19%41.49M59.12%34.41M193.89%134.03M21.50%28.44M280.30%55.78M325.85%28.19M2,265.97%21.63M
Cost of revenue 149.79%14.15M296.11%5.4M176.62%6.77M-2.25%1.56M64.45%421K419.16%5.66M183.16%1.36M863.39%2.45M419.16%1.6M433.33%256K
Gross profit 25.71%161.37M46.64%39.7M-10.47%47.75M50.16%39.93M59.05%33.99M188.37%128.37M18.10%27.07M270.03%53.33M321.29%26.59M2,367.55%21.37M
Operating expense 5.51%253.06M25.74%69.37M1.87%64.01M-10.35%56.1M7.29%63.57M6.48%239.84M-0.82%55.17M-2.99%62.83M17.09%62.58M15.25%59.25M
Selling and administrative expenses -0.68%195.04M5.47%50.07M-8.45%47.76M-8.64%47.08M10.90%50.12M13.16%196.37M6.05%47.47M16.85%52.17M16.27%51.53M13.55%45.2M
-General and administrative expense -0.68%195.04M5.47%50.07M-8.45%47.76M-8.64%47.08M10.90%50.12M13.16%196.37M6.05%47.47M16.85%52.17M16.27%51.53M13.55%45.2M
Research and development costs 10.34%49.64M3.63%10.23M23.99%13.61M9.76%12.65M4.26%13.16M-12.03%44.99M-11.47%9.87M-45.32%10.97M14.21%11.53M28.34%12.62M
Other operating expenses 650.16%8.38M518.16%9.07M950.48%2.65M-662.61%-3.63M-79.78%290K-365.33%-1.52M-661.40%-2.17M-665.45%-311K50.78%-476K-19.03%1.43M
Operating profit 17.74%-91.69M-5.60%-29.67M-71.21%-16.26M55.07%-16.17M21.90%-29.58M38.32%-111.47M14.08%-28.1M81.14%-9.5M23.65%-35.99M25.05%-37.88M
Net non-operating interest income expense 177.88%14.22M12.00%3.26M112.70%3.11M735.61%4.04M1,355.73%3.81M867.49%5.12M2,568.81%2.91M1,281.13%1.46M240.14%483K52.33%262K
Non-operating interest income 232.10%17M57.03%4.57M208.33%4.51M749.07%4.1M1,355.73%3.81M867.49%5.12M2,568.81%2.91M1,281.13%1.46M240.14%483K52.33%262K
Non-operating interest expense --2.78M--1.31M--1.4M--65K------0--0--0--0----
Other net income (expense)
Income before tax 27.16%-77.47M-4.86%-26.42M-63.65%-13.15M65.83%-12.13M31.50%-25.77M40.98%-106.35M22.72%-25.19M84.01%-8.04M24.44%-35.51M25.31%-37.62M
Income tax -69.86%551K-46.32%459K-68.76%298K-7,233.33%-642K4,260.00%436K140.53%1.83M17.77%855K11,825.00%954K-50.00%9K25.00%10K
Net income 27.88%-78.02M-3.18%-26.88M-49.59%-13.45M67.64%-11.49M30.36%-26.21M40.22%-108.18M21.84%-26.05M82.11%-8.99M24.45%-35.52M25.31%-37.63M
Net income continuous Operations 27.88%-78.02M-3.18%-26.88M-49.59%-13.45M67.64%-11.49M30.36%-26.21M40.22%-108.18M21.84%-26.05M82.11%-8.99M24.45%-35.52M25.31%-37.63M
Minority interest income
Net income attributable to the parent company 27.88%-78.02M-3.18%-26.88M-49.59%-13.45M67.64%-11.49M30.36%-26.21M40.22%-108.18M21.84%-26.05M82.11%-8.99M24.45%-35.52M25.31%-37.63M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 27.88%-78.02M-3.18%-26.88M-49.59%-13.45M67.64%-11.49M30.36%-26.21M40.22%-108.18M21.84%-26.05M82.11%-8.99M24.45%-35.52M25.31%-37.63M
Basic earnings per share 28.95%-0.540.00%-0.18-50.00%-0.0968.00%-0.0833.33%-0.1845.71%-0.7628.00%-0.1884.62%-0.0632.43%-0.2532.50%-0.27
Diluted earnings per share 28.95%-0.540.00%-0.18-50.00%-0.0968.00%-0.0833.33%-0.1845.71%-0.7628.00%-0.1884.62%-0.0632.43%-0.2532.50%-0.27
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg